NFG
PBE icon

Next Financial Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Next Financial Group’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$258K Sell
3,619
-1,080
-23% -$78.2K 0.02% 798
2021
Q3 		$352K Sell
4,699
-10
-0.2% -$762 0.03% 602
2021
Q2 		$364K Sell
4,709
-18
-0.4% -$1.34K 0.03% 591
2021
Q1 		$349K Sell
4,727
-434
-8% -$32.8K 0.03% 556
2020
Q4 		$362K Buy
5,161
+206
+4% +$13K 0.03% 488
2020
Q3 		$281K Buy
4,955
+108
+2% +$6.34K 0.03% 519
2020
Q2 		$282K Buy
4,847
+640
+15% +$34.9K 0.03% 438
2020
Q1 		$196K Buy
4,207
+4
+0.1% +$209 0.03% 535
2019
Q4 		$235K Buy
4,203
+1,465
+54% +$76.4K 0.02% 639
2019
Q3 		$130K Hold
2,738
– – 0.01% 825
2019
Q2 		$147K Buy
2,738
+338
+14% +$17.5K 0.02% 769
2019
Q1 		$132K Sell
2,400
-1,035
-30% -$54.7K 0.03% 465
2018
Q4 		$162K Buy
3,435
+2,035
+145% +$105K 0.03% 442
2018
Q3 		$83K Buy
+1,400
New +$81.7K 0.04% 409
2017
Q4 		– Sell
-1,350
Closed -$67K – 1050
2017
Q3 		$67K Buy
1,350
+900
+200% +$42.7K 0.02% 618
2017
Q2 		$21K Buy
450
+250
+125% +$10.8K 0.01% 1059
2017
Q1 		$9K Hold
200
– – ﹤0.01% 1323
2016
Q4 		$8K Hold
200
– – ﹤0.01% 1752
2016
Q3 		$8K Hold
200
– – ﹤0.01% 1766
2016
Q2 		$7K Hold
200
– – ﹤0.01% 1331
2016
Q1 		$7K Sell
200
-100
-33% -$3.88K ﹤0.01% 1287
2015
Q4 		$15K Hold
300
– – 0.01% 1040
2015
Q3 		$13K Hold
300
– – ﹤0.01% 1117
2015
Q2 		$17K Hold
300
– – 0.01% 1064
2015
Q1 		$16K Hold
300
– – 0.01% 1082
2014
Q4 		$15K Buy
300
+100
+50% +$4.89K 0.01% 1101
2014
Q3 		$9K Buy
+200
New +$9.01K ﹤0.01% 1808

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PA
PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

Next Financial Group's PBE Position: Q4 2021 in Review

Next Financial Group reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 23% in Q4 2021, selling an estimated $78.2K and leaving 3,619 shares worth $258K. The position accounts for 0.02% of the portfolio, ranked #798.

Next Financial Group first reported a position in PBE in Q3 2014 and has held it in 27 quarters since. The position peaked at $364K in Q2 2021. 101 funds tracked by Wall St. Rank hold PBE as of Q4 2021.

  • Next Financial Group held 3,619 shares of Invesco Biotechnology & Genome ETF worth $258K as of Q4 2021.
  • Next Financial Group sold 1,080 Invesco Biotechnology & Genome ETF shares in Q4 2021, an estimated $78.2K.
  • Invesco Biotechnology & Genome ETF made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #798 holding.
  • Next Financial Group first reported a position in Invesco Biotechnology & Genome ETF in Q3 2014 and has held it in 27 quarters since.
  • Next Financial Group's Invesco Biotechnology & Genome ETF position peaked at $364K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.